Get the Stockscreener App
153.79
1.43%
-2.23
After Hours:
153.79
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $153.79, with a volume of 633.39K.
It is down -1.43% in the last 24 hours and down -8.58% over the past month.
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
See More
Previous Close:
$156.02
Open:
$155.25
24h Volume:
633.39K
Relative Volume:
1.02
Market Cap:
$8.34B
Revenue:
$1.97B
Net Income/Loss:
$-494.50M
P/E Ratio:
-16.68
EPS:
-9.22
Net Cash Flow:
$137.20M
1W Performance:
-4.70%
1M Performance:
-8.58%
6M Performance:
-11.73%
1Y Performance:
+43.76%
1-Day Range:
$152.73
$158.81
1-Week Range:
$152.73
$165.20
52-Week Range:
$101.61
$194.88
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
153.79 | 8.46B | 1.97B | -494.50M | 137.20M | -9.22 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-27-24 | Reiterated | Raymond James | Outperform |
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
What makes Masimo Corporation stock price move sharplyTrade Setups With Clear Risk Limits Highlighted - beatles.ru
What technical models suggest about Masimo Corporation’s comebackDay Trading Signals With High Precision Reviewed - metal.it
Custom Dashboard Highlights Masimo Corporation Price MomentumVerified Signal From Chart Patterns Detected - metal.it
Former Masimo COO Bilal Muhsin Joins BD - Orange County Business Journal
How many analysts rate Masimo Corporation as a “Buy”Capitalize on trading strategies that deliver - jammulinksnews.com
Is Masimo Corporation stock overvalued or undervaluedBreakthrough investment results - jammulinksnews.com
What are analysts’ price targets for Masimo Corporation in the next 12 monthsStay informed with daily expert analysis - jammulinksnews.com
What analysts say about Masimo Corporation stockUnprecedented profit potential - PrintWeekIndia
What drives Masimo Corporation stock priceExtraordinary profit generation - Autocar Professional
Masimo Corporation Stock Analysis and ForecastExplosive capital appreciation - Autocar Professional
Is Masimo Corporation a good long term investmentRemarkable growth - jammulinksnews.com
Lobbying Update: $110,000 of MASIMO CORPORATION lobbying was just disclosed - Quiver Quantitative
Masimo Corp. Settles Investor Suit Over Revenue Disclosures - Law360
Samsung to buy US health tech firm Xealth in digital health push - KED Global
Masimo Criticizes Bid To DQ Quinn Emanuel In Payout Suit - Law360
Joe Kiani Appointed CEO of Santa Monica Media Company - Orange County Business Journal
Here's How Much You Would Have Made Owning Masimo Stock In The Last 10 Years - Benzinga
Masimo Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation - MarketScreener
Apple wants U.S. appeals court to overturn decision that forced it to remove blood-oxygen reading tech from the Apple Watch - MacTech.com
Europe Respiratory Care Devices Market Forecast and Company Analysis Report 2025-2033 Featuring Medtronic, Koninklijke Philips, GE, Masimo, ResMedInc, BD and Co, Chart Industries, Getinge - Yahoo Finance
Neuraxis ends Masimo license agreement and launches employee stock plan - Investing.com
5 Federal Circuit Clashes To Watch In July - Law360
Piper Sandler reiterates Masimo stock rating, cites new CEO impact By Investing.com - Investing.com South Africa
Masimo Fails to Disqualify Law Firm on Ousted Founder’s Team (1) - Bloomberg Law News
This Week in Chancery Court: Atlas Energy Solutions, Masimo (1) - Bloomberg Law News
Multiple Executive Changes Announced by Masimo; COO Muhsin to Resign July 1 - Strata-gee.com
Masimo COO to Resign - Orange County Business Journal
MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties - GlobeNewswire Inc.
New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia - marketscreener.com
Rhumbline Advisers Cuts Stock Holdings in Masimo Co. (NASDAQ:MASI) - MarketBeat
New Masimo CEO Katie Szyman Reveals Personal Ties to Device Maker - Orange County Business Journal
Masimo Fights Ex-CEO's Bid To Ax Suit Over $450M Demand - Law360
Masimo Corp (MASI) Stock Price Up 3.31% on Jun 6 - GuruFocus
Transcript : Masimo Corporation Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 01 - MarketScreener
MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties - Business Wire
Here's How Much $100 Invested In Masimo 15 Years Ago Would Be Worth Today - Benzinga
Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI) - Yahoo Finance
BTIG maintains Buy on Masimo stock with $193 price target - Investing.com India
BTIG maintains Buy on Masimo stock with $193 price target By Investing.com - Investing.com Canada
Masimo Founder Slaps Board With Lawsuit Over His Ouster - Law360
Is the Market Bullish or Bearish on Masimo? - Benzinga
Masimo Updates SEC on Its Progress Recovering From Recent Cyberattack - Strata-gee.com
Masimo (MASI) Reaffirms 2025 Outlook Despite Cybersecurity Incident - GuruFocus
Masimo Corporation: Will The Sound United Divestiture & Financial Realignment Efforts Meet Their Ultimate Goal? - Smartkarma
Masimo Corp (MASI) Trading 3.93% Higher on May 27 - GuruFocus
Masimo (MASI) Reassures Investors on Financial Outlook | MASI Stock News - GuruFocus
Masimo rallies after saying cyber attack won’t hurt 2025 sales - TipRanks
Masimo Corp maintains outlook despite cyber incident By Investing.com - Investing.com South Africa
Masimo Corp maintains outlook despite cyber incident - Investing.com
Masimo Leadership Takes Stage at Jefferies Healthcare Conference: Key Investor Presentation Coming June 4 - Stock Titan
Masimo (MASI) Reassures Investors on Financial Outlook | MASI St - GuruFocus
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):